Teva Branded Pharmaceutical Products R&D, Inc. | Teva Pharmaceutical Industries | Pennsylvania | state | 2013 | $5,485,485 | | tax credit/rebate |
Teva Pharmaceuticals | Teva Pharmaceutical Industries | Kansas | state | 2014 | $3,861,454 | | grant |
Teva Branded Pharmaceutical Products R&D, Inc. | Teva Pharmaceutical Industries | Pennsylvania | state | 2014 | $6,118,950 | | tax credit/rebate |
Teva Pharmaceuticals | Teva Pharmaceutical Industries | Kansas | local | 2016 | $31,654 | | tax credit/rebate |
Teva Biopharmaceuticals USA, Inc. | Teva Pharmaceutical Industries | Maryland | state | 2015 | $53,885 | | tax credit/rebate |
Teva Biopharmaceuticals USA, Inc. | Teva Pharmaceutical Industries | Maryland | state | 2016 | $76,366 | | tax credit/rebate |
Teva Pharmaceuticals USA, Inc. | Teva Pharmaceutical Industries | Pennsylvania | state | 2017 | $137,235 | | tax credit/rebate |
Teva Biopharmaceuticals USA, Inc. | Teva Pharmaceutical Industries | Maryland | state | 2017 | $30,972 | | tax credit/rebate |
Teva Pharmaceuticals | Teva Pharmaceutical Industries | Kansas | local | 2017 | $37,036 | | tax credit/rebate |
Teva Pharmaceuticals | Teva Pharmaceutical Industries | Kansas | local | 2018 | $36,371 | | tax credit/rebate |
Teva Pharmaceuticals USA, Inc. | Teva Pharmaceutical Industries | Kansas | state | 2016 | undisclosed | | grant |
Teva Pharmaceuticals USA, Inc. | Teva Pharmaceutical Industries | Kansas | state | 2017 | undisclosed | | grant |
Teva Pharmaceuticals USA, Inc. | Teva Pharmaceutical Industries | Kansas | state | 2018 | undisclosed | | grant |
Teva Pharmceuticals USA Inc. | Teva Pharmaceutical Industries | New Jersey | State | 2018 | $39,998,730 | | tax credit/rebate |
Takeda Pharmaceuticals North America, Inc. | Takeda Pharmaceutical | Illinois | state | 2005 | undisclosed | | tax credit/rebate |
Takeda Pharmaceuticals North America, Inc. | Takeda Pharmaceutical | Illinois | state | 2006 | undisclosed | | tax credit/rebate |
Takeda Pharmaceuticals North America, Inc. | Takeda Pharmaceutical | Illinois | state | 2007 | undisclosed | | tax credit/rebate |
Takeda Pharmaceuticals North America, Inc. | Takeda Pharmaceutical | Illinois | state | 2008 | $2,034,824 | | tax credit/rebate |
Takeda Pharmaceuticals North America, Inc. | Takeda Pharmaceutical | Illinois | state | 2009 | $4,511,785 | | tax credit/rebate |
Takeda Pharmaceuticals North America, Inc. | Takeda Pharmaceutical | Illinois | state | 2006 | $350,000 | | grant |
Takeda Pharmaceuticals North America, Inc. | Takeda Pharmaceutical | Illinois | state | 2007 | $350,000 | | grant |
Takeda Pharmaceuticals North America, Inc. | Takeda Pharmaceutical | Illinois | state | 2005 | $952,634 | | tax credit/rebate |
Takeda Pharmaceuticals North America, Inc. | Takeda Pharmaceutical | Illinois | state | 2006 | $1,384,120 | | tax credit/rebate |
Takeda Pharmaceuticals North America, Inc. | Takeda Pharmaceutical | Illinois | state | 2007 | undisclosed | | tax credit/rebate |
Takeda Pharmaceuticals North America, Inc. | Takeda Pharmaceutical | Illinois | state | 2008 | undisclosed | | tax credit/rebate |
Takeda Pharmaceuticals North America, Inc. | Takeda Pharmaceutical | Illinois | state | 2009 | $1,105,019 | | tax credit/rebate |
Shire Pharmaceuticals, Inc. | Takeda Pharmaceutical | Pennsylvania | state | | $1,200,000 | | tax credit/rebate |
Shire Pharmaceuticals, Inc. | Takeda Pharmaceutical | Pennsylvania | state | | $2,000,000 | | grant |
Shire Pharmaceuticals Inc. | Takeda Pharmaceutical | Pennsylvania | state | 2008 | $402,051 | | tax credit/rebate |
Shire Pharmaceuticals, Inc. | Takeda Pharmaceutical | Pennsylvania | state | 2009 | $246,912 | | tax credit/rebate |
Shire Pharmaceuticals, Inc. | Takeda Pharmaceutical | Pennsylvania | state | 2010 | $228,422 | | tax credit/rebate |
Shire HGT, Inc. | Takeda Pharmaceutical | Massachusetts | state | 2011 | $5,855,368 | | tax credit/rebate |
Shire HGT, Inc. | Takeda Pharmaceutical | Massachusetts | state | 2011 | $3,500,000 | | tax credit/rebate |
Shire Human Genetics Therapies, Inc. | Takeda Pharmaceutical | Massachusetts | state | 2007 | undisclosed | | tax credit/rebate |
NPS Pharmaceuticals, Inc. | Takeda Pharmaceutical | New Jersey | state | 2003 | $4,371,200 | | grant |
Shire Human Genetic Therapies, Inc | Takeda Pharmaceutical | Massachusetts | state | 2012 | $3,000,000 | | tax credit/rebate |
Viropharma Incorporated | Takeda Pharmaceutical | Pennsylvania | state | | $453,000 | | tax credit/rebate |
Shire US Manufacturing, Inc. | Takeda Pharmaceutical | Maryland | state | 2004 | $26,595 | | training reimbursement |
Shire US Manufacturing, Inc. | Takeda Pharmaceutical | Maryland | state | 2008 | $24,791 | | training reimbursement |
Shire US Manufacturing Inc. | Takeda Pharmaceutical | Maryland | state | 2007 | $23,191 | | training reimbursement |
Shire Holdings US, AG | Takeda Pharmaceutical | Maryland | state | 2004 | $588,423 | | tax credit/rebate |
Shire Holdings US, AG | Takeda Pharmaceutical | Maryland | state | 2005 | $53,032 | | tax credit/rebate |
Shire Holding US AG | Takeda Pharmaceutical | Maryland | state | 2008 | $33,609 | | tax credit/rebate |
Shire US Manufacturing, Inc. | Takeda Pharmaceutical | Maryland | state | 2009 | $30,126 | | tax credit/rebate |
Shire Holdings US AG | Takeda Pharmaceutical | Maryland | state | 2007 | $27,738 | | tax credit/rebate |
Shire Human Genetic Therapies, Inc. | Takeda Pharmaceutical | Massachusetts | state | 2013 | $750,000 | | tax credit/rebate |
ARIAD Pharmaceuticals, Inc. | Takeda Pharmaceutical | Massachusetts | state | 2013 | $1,225,000 | | tax credit/rebate |
Shire US Holdings, Inc. | Takeda Pharmaceutical | Pennsylvania | state | 2013 | $255,775 | | tax credit/rebate |
Shire US Holdings, Inc. | Takeda Pharmaceutical | Pennsylvania | state | 2014 | $914,646 | | tax credit/rebate |
Shire Human Genetic Therapies | Takeda Pharmaceutical | Massachusetts | state | 2014 | $597,076 | | tax credit/rebate |
Shire Holdings US, AG | Takeda Pharmaceutical | Pennsylvania | state | 2015 | $1,223,167 | | tax credit/rebate |
Shire ViroPharma Incorporated | Takeda Pharmaceutical | Pennsylvania | state | 2015 | $312,596 | | tax credit/rebate |
Shire Human Genetic Therapies, Inc. | Takeda Pharmaceutical | Pennsylvania | state | 2015 | $85,593 | | tax credit/rebate |
BioLife Plasma Services L.P. | Takeda Pharmaceutical | Idaho | state | 2011 | $523,620 | | training reimbursement |
Shire Holdings US, AG | Takeda Pharmaceutical | Pennsylvania | state | 2016 | $621,710 | | tax credit/rebate |
Shire Human Genetic Therapies, Inc. | Takeda Pharmaceutical | Pennsylvania | state | 2016 | $118,253 | | tax credit/rebate |
Shire ViroPharma, Inc. | Takeda Pharmaceutical | Pennsylvania | state | 2016 | $85,794 | | tax credit/rebate |
Takeda Pharmaceuticals America | Takeda Pharmaceutical | West Virginia | state | 2010 | undisclosed | | tax credit/rebate |
Shire Human Genetic Therapies, Inc. | Takeda Pharmaceutical | Pennsylvania | state | 2017 | $160,094 | | tax credit/rebate |
Shire Human Genetic Therapies | Takeda Pharmaceutical | Massachusetts | state | 2015 | $985,000 | | tax credit/rebate |
Takeda Pharmaceuticals America, Inc. | Takeda Pharmaceutical | Massachusetts | state | 2016 | $1,125,000 | | tax credit/rebate |
Baxalta. Inc. | Takeda Pharmaceutical | Massachusetts | state | 2016 | $1,320,000 | | tax credit/rebate |
SHIRE HUMAN GENETIC THERAPIES INC | Takeda Pharmaceutical | Pennsylvania | state | 2020 | $121,300 | | tax credit/rebate |
Shire Human Genetic Therapies Inc | Takeda Pharmaceutical | Pennsylvania | state | 2021 | $294,400 | | tax credit/rebate |
Baxalta Us Inc | Takeda Pharmaceutical | California | state | 2022 | $20,998 | | training reimbursement |
Supernus Pharmaceuticals, Inc. | Supernus Pharmaceuticals | Maryland | state | 2007 | $15,373 | | training reimbursement |
Supernus Pharmaceuticals | Supernus Pharmaceuticals | Maryland | local | 2018 | $500,000 | | grant/loan hybrid program |
Supernus Pharmaceuticals | Supernus Pharmaceuticals | Maryland | local | 2018 | $500,000 | | grant/loan hybrid program |
Supernus Pharmaceuticals, Inc. | Supernus Pharmaceuticals | Maryland | state | 2018 | $44,733 | | training reimbursement |
Supernus Pharmaceuticals, Inc. | Supernus Pharmaceuticals | Maryland | state | 2018 | $38,025 | | tax credit/rebate |
Supernus Pharmaceuticals, Inc. | Supernus Pharmaceuticals | Maryland | state | 2019 | $62,460 | | tax credit/rebate |
Supernus Pharmaceuticals, Inc. | Supernus Pharmaceuticals | Maryland | state | 2020 | $65,492 | | tax credit/rebate |
Supernus Pharmaceuticals, Inc. | Supernus Pharmaceuticals | Maryland | state | 2021 | $100,088 | | tax credit/rebate |
Supernus Pharmaceuticals, Inc. | Supernus Pharmaceuticals | Maryland | state | 2022 | $0 | $800,000 | grant/loan hybrid program |
Supernus Pharmaceuticals | Supernus Pharmaceuticals | Maryland | local | 2019 | $500,000 | | grant/loan hybrid program |
Mutual Pharmaceutical Company, Inc. | Sun Pharmaceuticals | Pennsylvania | state | | $975,000 | | tax credit/rebate |
Mutual Pharmaceutical Company, Inc. | Sun Pharmaceuticals | Pennsylvania | state | | $650,000 | | grant |
Mutual Pharmaceutical Company, Inc. | Sun Pharmaceuticals | Pennsylvania | state | | | $1,250,000 | loan or bond financing |
Mutual Pharmaceutical Company, Inc. | Sun Pharmaceuticals | Pennsylvania | state | 2008 | $570,051 | | tax credit/rebate |
Mutual Pharmaceutical Company, Inc. | Sun Pharmaceuticals | Pennsylvania | state | 2009 | $97,635 | | tax credit/rebate |
Mutual Pharmaceutical Company, Inc. | Sun Pharmaceuticals | Pennsylvania | state | 2010 | $97,100 | | tax credit/rebate |
Taro Pharmaceuticals U.S.A., Inc. | Sun Pharmaceuticals | New Jersey | state | 2003 | $1,287,195 | | grant |
Sun Pharmaceutical Industries, Inc. | Sun Pharmaceuticals | New Jersey | state | 2008 | $2,382,217 | | grant |
SEATTLE GENETICS INC | Seattle Genetics Inc. | Washington | state | 2004 | $85,688 | | tax credit/rebate |
SEATTLE GENETICS INC | Seattle Genetics Inc. | Washington | state | 2005 | $141,146 | | tax credit/rebate |
SEATTLE GENETICS INC | Seattle Genetics Inc. | Washington | state | 2006 | $64,881 | | tax credit/rebate |
SEATTLE GENETICS INC | Seattle Genetics Inc. | Washington | state | 2007 | $425,295 | | tax credit/rebate |
SEATTLE GENETICS INC | Seattle Genetics Inc. | Washington | state | 2008 | $239,698 | | tax credit/rebate |
SEATTLE GENETICS INC | Seattle Genetics Inc. | Washington | state | 2009 | $543,597 | | tax credit/rebate |
SEATTLE GENETICS INC | Seattle Genetics Inc. | Washington | state | 2010 | $131,488 | | tax credit/rebate |
ONCOTHYREON INC | Seattle Genetics Inc. | Washington | state | 2010 | $8,801 | | tax credit/rebate |
ONCOTHYREON INC | Seattle Genetics Inc. | Washington | state | 2011 | $2,611 | | tax credit/rebate |
SEATTLE GENETICS INC | Seattle Genetics Inc. | Washington | state | 2011 | $18,072 | | tax credit/rebate |
ONCOTHYREON INC | Seattle Genetics Inc. | Washington | state | 2011 | $19,669 | | tax credit/rebate |
SEATTLE GENETICS INC | Seattle Genetics Inc. | Washington | state | 2011 | $51,253 | | tax credit/rebate |
SEATTLE GENETICS INC | Seattle Genetics Inc. | Washington | state | 2004 | $40,481 | | tax credit/rebate |
SEATTLE GENETICS INC | Seattle Genetics Inc. | Washington | state | 2006 | $156,516 | | tax credit/rebate |
SEATTLE GENETICS INC | Seattle Genetics Inc. | Washington | state | 2008 | $156,516 | | tax credit/rebate |
SEATTLE GENETICS INC | Seattle Genetics Inc. | Washington | state | 2009 | $156,516 | | tax credit/rebate |
ONCOTHYREON INC | Seattle Genetics Inc. | Washington | state | 2010 | $19,669 | | tax credit/rebate |
SEATTLE GENETICS INC | Seattle Genetics Inc. | Washington | state | 2010 | $51,253 | | tax credit/rebate |